NDT Pharmaceuticals Inc (NDTP)

[Ecomike]

We tracked down the original CCA NPC to Hovis in 2007, and Dr. Michael Fountain in in 2007 and then in 2010 at Univ of So. Florida, with 4 Federal agencies funding the 2010 R&D.

Then in 2013 Hovis, Fountain and the CCA founders all started working with UPennMed Med on TBI project (clearly documented, to some extent in the 2010 University paper Fountain co-authored) in a JV.

It is possible the CCA/UPennMed NPC was going to used the Dr. Mark Kester's Ceramide Phase III approved Cancer trial that was approved in late 2019, as the time of the take over the shell, now NDTP, was the same week Keystone Nano got the FDA Phase III approval and the day Keystone went dark on news and social Media..

The key problem here is this CEO and the Founders/Insiders are not acting like their shares are worth more than .0001 based on this clown-CEO's resent self serving actions
gifting himself 40 Million shares.

And they have no working website. WTF is that all about?

The last clown act on the cook books (IMO) deal was so obvious that it brings doubt as to the value or motives of the person in control and who ever gave him that control.

Public companies are required to be transparent. And real 3rd grade math skills are also important. But have been missing here at times requiring filing corrections.

Last year I wrote it off to Hovis's health issues. 2020-2022 I wrote the delays off to Covid19, that seemed obvious, and then July 2022, the death of Mark Kester was huge set back.

But the recent failed plan and attempt to apparently cook the books with what looked like an obvious overseas cook the book and up list to Nasdaq plan from the EU (The Kind figured out and stopped before, scams) R/M for barely out of the cradle drug trials, that would needs 100's of millions of dollars for 5-10 years of cash burn, while generating no revenue, plan to wipe us out with second R/S of 100:1 after a 1000:1 R/S is simply unethical white collar crime at the highest level, with no sign of anyone exhibiting any fiduciary responsibility here except the retail shareholders.